LigaChem Biosciences Inc.
Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.
141080 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 국제과학10로 10 (주)레고켐 바이오사이언스, 대전광역시
- Website:
- https://ligachembio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
LigaChem Biosciences Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines for unmet medical needs. The company specializes in research and development focused on Antibody-Drug Conjugates (ADCs), immuno-oncology, and synthetic small molecule drugs. Its core strength is a proprietary, next-generation ADC platform technology engineered to overcome the limitations of conventional ADCs. LigaChem Biosciences accelerates global drug development through an open innovation model, actively pursuing co-research, co-development, and licensing agreements with global partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-09 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 공동연구 및 항체 기술도입 계약 체결)
|
Korean | 10.5 KB | ||
| 2025-08-26 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (LCB97관련 마일스톤 기술료 수령)
|
Korean | 7.7 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 3.7 MB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.5 KB | ||
| 2025-06-27 00:00 |
Major Shareholding Notification
신탁계약에의한취득상황보고서
|
Korean | 21.5 KB | ||
| 2025-06-26 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.3 KB | ||
| 2025-06-11 00:00 |
Regulatory News Service
투자판단관련주요경영사항 ('LCB97'관련 마일스톤 기술료 수령)
|
Korean | 8.7 KB | ||
| 2025-06-05 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 공동연구 및 항체 기술도입 계약 체결)
|
Korean | 10.7 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.5 MB | ||
| 2025-05-13 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (신규 항체-약물 결합체(ADC) 연구개발을 위한 항체 기술도입 계약 체결)
|
Korean | 10.5 KB | ||
| 2025-04-15 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 21.4 KB | ||
| 2025-04-11 00:00 |
Regulatory News Service
신탁계약해지결과보고서
|
Korean | 22.7 KB | ||
| 2025-04-08 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 28.2 KB | ||
| 2025-04-08 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 34.8 KB | ||
| 2025-03-31 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 20.5 KB |
Automate Your Workflow. Get a real-time feed of all LigaChem Biosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for LigaChem Biosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
